Fig. 4: ROC curves for CPS and TPS based on objective response per RECIST v1.1. | Modern Pathology

Fig. 4: ROC curves for CPS and TPS based on objective response per RECIST v1.1.

From: Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

Fig. 4

a ROC curve for CPS by treatment group. b YI plots for CPS by treatment group. c ROC curve for TPS by treatment group. d YI plots for TPS by treatment group. AUROC area under the receiver operating characteristics, CPS combined positive score, PD-L1 programmed death ligand 1, SOC standard of care, TPS tumor proportion score.

Back to article page